Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
4(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
3
38%
Ph phase_1
1
13%
Ph phase_3
4
50%

Phase Distribution

1

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 3Large-scale testing
4(50.0%)
Phase 4Post-market surveillance
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(2)
Other(2)

Detailed Status

Recruiting4
Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 34 (50.0%)
Phase 43 (37.5%)

Trials by Status

completed225%
unknown225%
recruiting450%

Recent Activity

4 active trials
Showing 5 of 8
recruitingphase_4

LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery

NCT07168421
completedphase_3

Prevention of Atrial Fibrillation by Low-dose Landiolol Administration After Cardiac Surgery

NCT04607122
recruitingphase_4

Landiolol in Mitral Valve Surgery

NCT06793670
recruitingphase_3

Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility

NCT04748796
completedphase_3

Landiolol in Postoperative Atrial Fibrillation

NCT03779178
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07168421Phase 4

LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery

Recruiting
NCT04607122Phase 3

Prevention of Atrial Fibrillation by Low-dose Landiolol Administration After Cardiac Surgery

Completed
NCT06793670Phase 4

Landiolol in Mitral Valve Surgery

Recruiting
NCT04748796Phase 3

Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility

Recruiting
NCT03779178Phase 3

Landiolol in Postoperative Atrial Fibrillation

Completed
NCT04931225Phase 3

LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)

Recruiting
NCT05554978Phase 1

Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest

Unknown
NCT04223739Phase 4

Comparison of Two Strategies for the Management of Atrial Fibrillation After Cardiac Surgery

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8